緑内障(Glaucoma)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Glaucoma - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Glaucoma Overview 11
Therapeutics Development 12
Pipeline Products for Glaucoma – Overview 12
Pipeline Products for Glaucoma – Comparative Analysis 13
Glaucoma – Therapeutics under Development by Companies 14
Glaucoma – Therapeutics under Investigation by Universities/Institutes 18
Glaucoma – Pipeline Products Glance 19
Late Stage Products 19
Clinical Stage Products 20
Early Stage Products 21
Unknown Stage Products 22
Glaucoma – Products under Development by Companies 23
Glaucoma – Products under Investigation by Universities/Institutes 29
Glaucoma – Companies Involved in Therapeutics Development 30
AC Immune SA 30
Acadia Pharmaceuticals Inc. 31
Aerie Pharmaceuticals, Inc. 32
Alcon, Inc. 33
Allergan, Inc. 34
Altacor Ltd. 35
Amakem NV 36
Asahi Kasei Pharma Corp. 37
AUS Bio Limited 38
Bausch & Lomb Incorporated 39
Bionure Farma, S.L. 40
Can-Fite BioPharma Ltd. 41
Cellular Biomedicine Group, Inc. 42
China Grand Wuhan General Pharmaceutical Research Institute 43
D. Western Therapeutics Institute, Inc. 44
DNAVEC Corporation 45
Dompe Farmaceutici S.p.A. 46
F. Hoffmann-La Roche Ltd. 47
Foamix Pharmaceuticals Ltd. 48
Gene Signal International SA 49
Gilead Sciences, Inc. 50
Handok Inc. 51
High Point Pharmaceuticals, LLC 52
Icon Bioscience, Inc. 53
IMMD Inc. 54
Inotek Pharmaceuticals Corporation 55
InSite Vision Incorporated 56
Lacer, S.A. 57
Merck & Co., Inc. 58
Merz Pharma GmbH & Co. KgaA 59
Mimetogen Pharmaceuticals Inc. 60
NeoStem, Inc. 61
Neurotech Pharmaceuticals, Inc. 62
NicOx S.A. 63
Ocata Therapeutics, Inc. 64
Ocular Therapeutix, Inc. 65
Ohr Pharmaceutical Inc. 66
Ono Pharmaceutical Co., Ltd. 67
Otsuka Holdings Co., Ltd. 68
Oxford BioMedica plc 69
PharmaNova Inc. 70
Quark Pharmaceuticals, Inc. 71
Santen Pharmaceutical Co., Ltd. 72
Senju Pharmaceutical Co., Ltd. 73
SIFI S.p.A 74
SK Biopharmaceuticals Co., Ltd. 75
Sun Pharma Advanced Research Company Ltd. 76
Sylentis S.A. 77
Teva Pharmaceutical Industries Limited 78
Upsher-Smith Laboratories, Inc. 79
Glaucoma – Therapeutics Assessment 80
Assessment by Monotherapy Products 80
Assessment by Combination Products 81
Assessment by Target 82
Assessment by Mechanism of Action 86
Assessment by Route of Administration 90
Assessment by Molecule Type 92
Drug Profiles 94
(AR-13324 + latanoprost) – Drug Profile 94
(bimatoprost + brimonidine tartrate) – Drug Profile 95
(carteolol hydrochloride + latanoprost) – Drug Profile 96
(dorzolamide hydrochloride + latanoprost) – Drug Profile 97
(latanoprost + trabodenoson) – Drug Profile 98
(Prostaglandin Agonist + Beta-Blocker) – Drug Profile 99
(tafluprost + timolol maleate) – Drug Profile 100
AC-262271 – Drug Profile 101
ACI-260 – Drug Profile 102
ACN-1052 – Drug Profile 103
aganirsen – Drug Profile 104
ALT-022 – Drug Profile 106
AMA-0076 – Drug Profile 107
Antibody to Inhibit Sema3A for Glaucoma and Optic Neuropathy – Drug Profile 108
AP-022 – Drug Profile 109
APH-1104 – Drug Profile 110
AR-13324 – Drug Profile 111
AR-13533 – Drug Profile 112
ATS-8535 – Drug Profile 113
BA-1049 – Drug Profile 114
BA-240 – Drug Profile 115
bimatoprost – Drug Profile 116
bimatoprost SR – Drug Profile 117
BN-201 – Drug Profile 118
CF-101 – Drug Profile 119
CNS-102 – Drug Profile 122
DE-117 – Drug Profile 123
dorzolamide hydrochloride nanoparticle – Drug Profile 124
Drugs for Steroid Induced Glaucoma – Drug Profile 125
Drugs to Inhibit Cadherin-5 for Glaucoma – Drug Profile 126
Drugs to Target Bestrophin-2 for Glaucoma – Drug Profile 127
ENV-515 – Drug Profile 128
GB-201 – Drug Profile 129
GB-202 – Drug Profile 130
GB-203 – Drug Profile 131
GB-204 – Drug Profile 132
Gene Therapy for Glaucoma and Retinitis Pigmentosa – Drug Profile 133
Gene Therapy for Ocular Diseases – Drug Profile 134
Gene Therapy for Steroid Induced Glaucoma and Ocular Hypertension – Drug Profile 135
Glaucoma-GT – Drug Profile 136
GS-607601 – Drug Profile 137
H-1129 – Drug Profile 138
H-1129 Backup – Drug Profile 139
HL-5521 – Drug Profile 140
HPP-851 – Drug Profile 141
IMD-1041 – Drug Profile 142
KR-12 – Drug Profile 143
LA-8045 – Drug Profile 144
latanoprost – Drug Profile 145
latanoprost – Drug Profile 146
latanoprost – Drug Profile 148
latanoprost – Drug Profile 149
latanoprost SR – Drug Profile 150
latanoprostene bunod – Drug Profile 152
lomerizine – Drug Profile 154
Lycium Anti-Angiogenic Proteoglycan – Drug Profile 155
MD-920G – Drug Profile 156
MIMD-3 – Drug Profile 157
minocycline Gel – Drug Profile 158
Monoclonal Antibody to Activate Bves for Glaucoma – Drug Profile 159
MRZ-99030 – Drug Profile 160
NB-1111 – Drug Profile 161
NCX-1021 – Drug Profile 162
NCX-250 – Drug Profile 163
Neurovitas – Drug Profile 164
NT-501 – Drug Profile 165
NT-509 – Drug Profile 167
ONO-9054 – Drug Profile 168
OPA-6566 – Drug Profile 169
PBF-695 – Drug Profile 170
PRX-00933 – Drug Profile 171
QPI-1007 – Drug Profile 172
R-807 – Drug Profile 173
Recombinant Human Nerve Growth Factor – Drug Profile 174
RO-5093151 – Drug Profile 175
SF-103 – Drug Profile 177
SF-108 – Drug Profile 178
SF-109 – Drug Profile 179
SF-116 – Drug Profile 180
SKL-G – Drug Profile 181
SKS-1002 – Drug Profile 182
Small Molecule for Glaucoma – Drug Profile 183
Small Molecule for Glaucoma – Drug Profile 184
Small Molecule to Inhibit Rho Kinase for Glaucoma – Drug Profile 185
Small Molecule to Inhibit Sema3A for Glaucoma and Optic Neuropathy – Drug Profile 186
Small Molecules for CNS Disorders and Ophthalmology – Drug Profile 187
Small Molecules to Activate sGC for Ophthalmology – Drug Profile 188
Small Molecules to Antagonize TRPM7 for Myocardial Ischemia and Glaucoma – Drug Profile 189
Small Molecules to Antagonize TRPV4 for Glaucoma – Drug Profile 190
Small Molecules to Inhibit LIMK1 AND LIMK2 for Cancer and Ophthalmology – Drug Profile 191
SNJ-1656 – Drug Profile 192
SNJ-1945 – Drug Profile 194
Stem Cell Therapy for Glaucoma – Drug Profile 195
Stem Cell Therapy for Glaucoma, Cerebral Palsy and Lupus – Drug Profile 196
Stem Cell Therapy for Macular Degeneration and Glaucoma – Drug Profile 197
Stem Cell Therapy for Ophthalmic Disorders – Drug Profile 198
SYL-040012 – Drug Profile 199
Synthetic Peptide for Glaucoma – Drug Profile 201
tafluprost – Drug Profile 202
trabodenoson – Drug Profile 204
travoprost SR – Drug Profile 205
TRV-32R – Drug Profile 206
XY-0811QF2 – Drug Profile 207
XY-1303LT2 – Drug Profile 208
Glaucoma – Recent Pipeline Updates 209
Glaucoma – Dormant Projects 230
Glaucoma – Discontinued Products 232
Glaucoma – Product Development Milestones 233
Featured News & Press Releases 233
Appendix 242
Methodology 242
Coverage 242
Secondary Research 242
Primary Research 242
Expert Panel Validation 242
Contact Us 243
Disclaimer 243


【レポート販売概要】

■ タイトル:緑内障(Glaucoma)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Glaucoma - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6016IDB
■ 調査対象地域:グローバル
  • 風力発電への投資動向:Investment in Wind Power
    One of the most important economic benefits of wind power is that it reduces the exposure of our economies to fuel price volatility. This coupled with the concern over greenhouse gas emissions, has prompted political attention on energy alternatives, and one of the most prominent ones has been wind power. Wind energy already plays a significant role in several European nations, and countries like …
  • バルーン椎骨形成の世界市場2015-2019
    About Balloon Kyphoplasty VCF is characterized by the collapse of one or more vertebral bodies, resulting in persistent and unbearable pain in patients. Osteoporosis, a degenerative bone disease, is a leading cause of VCF among elderly women. Metastatic bone disease, multiple myeloma, metastatic spinal tumors, and traumatic injuries also cause VCF. Individuals with VCF can undergo vertebroplasty a …
  • 蛋白質治療の世界市場2017-2021:mAbs、ヒトインスリン、凝固因子、EPO、ヒト成長ホルモン
    About Protein TherapeuticsTherapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis (RA), ankylosing spondylitis, diabetes; infections such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases …
  • 世界の水陸両用上陸用舟艇、エアクッション市場動向2014 – 2019
    The report presents the complete analysis and provides information about the global amphibious landing craft market across the time span of five years (2013-2019).It provides a brief description about the key drivers, challenges, and restraints affecting the global amphibious landing craft market. It also indicates the segmentation for the global landing craft market; the global market is further …
  • メタクリル酸グリシジルの世界市場2015
    Glycidyl Methacrylate (CAS 106-91-2) Market Research Report 2015 aims at providing comprehensive data on Glycidyl Methacrylate market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Glycidyl Methacrylate description, covers its application areas, manufacturing methods, patterns. It captures Glycidyl Methacrylate market trends, pays close attention to G …
  • デジタルポンプコントローラーの世界市場展望2017-2026
    According to Stratistics MRC, the Global Digital Pump Controller market accounted for $ 8.19 billion in 2017 and is expected to reach $ 15.85 billion by 2026 growing at a CAGR of 7.6% during the forecast period. Some of the key factors such as the increasing usage of connected devices like smartphones, laptops etc. and the installation of water pumps across all over the globe are driving the marke …
  • PegIntron (Hepatitis C Virus):市場予測と分析(~2022)
    PegIntron (Hepatitis C Virus) - Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no effective vaccine against HCV, so the market is driven by therapeutics. Curr …
  • メキシコの使い捨て病院用品市場見通し(~2021)
    Mexico Disposable Hospital Supplies Market Outlook to 2021 Summary GlobalData’s new report, "Mexico Disposable Hospital Supplies Market Outlook to 2021", provides key market data on the Mexico Disposable Hospital Supplies market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Procedure Kits and Trays, Gloves, …
  • グローバル通信産業における構造化データ、ビックデータ及び分析市場
    The telecommunications industry is investing heavily in developing the analytical tools and services to take advantage of both their traditional structured data and unstructured (big) data resources. The goals of each carrier program vary, but share some commonalities including the desire to improve business intelligence gathering, customer care and operations. Carriers are also working diligently …
  • ドイツの感染症検査市場2014
    This report provides an overview of the German infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Table of ContentsBusiness EnvironmentMarket Structure  Market Size, Growth, and Major Suppliers' Market SharesList of Tables            &n …
  • 世界におけるデータセンターの物理的セキュリティー市場動向(2014-2018)
    About Data Center Physical Security Data center physical security is the monitoring of data center hardware and facilities to protect them from external threats and intrusions. Enterprise and data center service providers are adopting various types of equipment and solutions to facilitate efficient monitoring and management of entry into data center facilities. Physical security equipment includes …
  • データセンターラックPDUの世界市場2017-2021
    About Data Center Rack Power Distribution UnitIn a data center environment, a rack PDU is used to supply power to a server rack. Rack-mounted PDUs are available in different sizes and configurations. These traits depend on the type of connection and voltage each unit requires to function. PDUs are classified based on functionalities, including power filtering, remote monitoring, control by local a …
  • 衣類用柔軟剤の世界市場2015-2019     
    About fabric conditioners Fabric conditioners are easy-to-degrade cationic surfactants that contain fragrances (natural/artificial), coloring agents, and preservatives such as bronopol, formaldehyde, and chloride. Apart from making the clothes soft, fabric conditioners are used to give a long-lasting pleasant fragrance to garments. They also make clothes less static and easy for ironing. Technavio …
  • マッサージオイルの世界市場2016-2020
    About Global Massage Oil Market Massage oils stimulate the tissues of the body when they are massaged into the skin, improving health conditions and rejuvenating the mind and body. There are different types of massage oils such as apricot kernel oil, sweet almond oil, coconut oil, jojoba oil, sunflower oil, avocado oil, grapeseed oil, Kukui nut oil, olive oil, sesame oil, and wheat germ oil. These …
  • 次世代メモリの世界市場予測(~2023年):HMC、HBM、MRAM、FRAM、RERAM、3D XPoint、NRAM
    The next-generation memory (NGM) market is expected to grow from USD 2.35 Billion by 2017 to USD 9.68 Billion by 2023, at a CAGR of 26.54% between 2017 and 2023. The major drivers for the growth of the NGM market are big data demand for universal memory devices; increasing demand for enterprise storage application; and need for high bandwidth, low power consumption, and highly scalable memory devi …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。